Evolva Holding SA

Swiss Stock Exchange EVE.SW

Evolva Holding SA Gross Profit Margin for the year ending December 31, 2023: -27.36%

Evolva Holding SA Gross Profit Margin is -27.36% for the year ending December 31, 2023, a 52.18% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.
  • Evolva Holding SA Gross Profit Margin for the year ending December 31, 2022 was -57.22%, a 63.70% change year over year.
  • Evolva Holding SA Gross Profit Margin for the year ending December 31, 2021 was -157.66%, a -19.92% change year over year.
  • Evolva Holding SA Gross Profit Margin for the year ending December 31, 2020 was -131.47%, a -519.61% change year over year.
  • Evolva Holding SA Gross Profit Margin for the year ending December 31, 2019 was -21.22%, a -189.53% change year over year.
Key data
Date Gross Profit Margin Operating Income Margin EBT Margin Net Income Margin
Market news
Loading...
SV Wall Street
Swiss Stock Exchange: EVE.SW

Evolva Holding SA

CEO Mr. Gerhard Lobmaier
IPO Date May 3, 2005
Location Switzerland
Headquarters Duggingerstrasse 23
Employees 49
Sector Consumer Discretionary
Industries
Description

Evolva Holding SA discovers, researches, develops, and commercializes nature-based ingredients for use in flavor and fragrances, health ingredients, health protection, and other sectors in Switzerland, the United States, and internationally. It offers various ingredients comprising Veri-te Resveratrol, a nature-made polyphenol that occurs naturally in grapes and other plants, including peanuts, cranberries, and berries; L-Arabinose, a flavoring agent used in Maillard reaction; Valencene, an aroma component of citrus fruit and citrus-derived odorants; Nootkatone, an aroma ingredient of grapefruit obtained via biochemical oxidation of valencene; and Vanillin, a primary component of vanilla bean extract. The company was founded in 2004 and is headquartered in Reinach, Switzerland.

Similar companies

BSLN.SW

Basilea Pharmaceutica AG

USD 45.08

2.29%

SANN.SW

Santhera Pharmaceuticals Holding AG

USD 18.70

3.10%

MBTN.SW

Meyer Burger Technology AG

USD 1.86

3.49%

StockViz Staff

February 6, 2025

Any question? Send us an email